A novel technology for home monitoring of lupus nephritis that tracks the pathogenic urine biomarker ALCAM
Abstract
The gold standard for diagnosis of active lupus nephritis (ALN), a kidney biopsy, is invasive with attendant morbidity and cannot be serially repeated. Urinary ALCAM (uALCAM) has shown high diagnostic accuracy for renal pathology activity in ALN patients.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Dec 09, 2022
- Source ID
- 10.3389/fimmu.2022.1044743
Entities
People
- Adheesha N Danthanarayana
- Binh Vu
- Chandra Mohan
- Jakoah Brgoch
- Katerina Kourentzi
- Michelle Petri
- Richard C Willson
- Rongwei Lei
- Sanam Soomro
- Suma Nadimpalli
Organizations
- Centers for Disease Control and Prevention
- National Institutes of Health
- United States Department of Defense